TargetMol Chemicals Inc. 公司信息

公司名稱: TargetMol Chemicals Inc.

電話: -

電子郵件:marketing@targetmol.com

國籍:美國

產(chǎn)品總數(shù):32368

152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256

公司提供產(chǎn)品列表

Rituximab		174722-31-7
Infliximab		170277-31-3
Masitinib mesylate		1048007-93-7
Tenovin-6 Hydrochloride		1011301-29-3
SEP-0372814		1516895-53-6
BMS-1001		2113650-03-4
Metformin		657-24-9
THPP-1		1257051-63-0
5-Methylfurfural		620-02-0
Dantrolene		7261-97-4
NPS2390		226878-01-9
Spinorphin		137201-62-8
Tetrazole		27988-97-2
Pembrolizumab		1374853-91-4
AC1903		831234-13-0
Omalizumab		242138-07-4
RA-9		919091-63-7
EIDD-1931		3258-02-4
UNC1079		1418741-86-2
Daratumumab		945721-28-8
TLR4-IN-C34		40592-88-9
TC-I2000		1159996-20-9
Vanillic Acid		121-34-6
SX-682		1648843-04-2
BMS-345541 hydrochloride		547757-23-3
Vonafexor		1192171-69-9
Enoximone		77671-31-9
SC-236		170569-86-5
Filastatin		431996-53-1
CNQX disodium		479347-85-8
Empesertib		1443763-60-7
Vorolanib		1013920-15-4
Butoconazole		64872-76-0
β-Caryophyllene		87-44-5
Pulegone		89-82-7
CPYPP		310460-39-0
Cysteine thiol probe		1947408-74-3
IM156		1422365-93-2
Tyrphostin AG 112		144978-82-5
Levomenol		23089-26-1
Bevacizumab		216974-75-3
Yohimbine		146-48-5
Matuzumab		339186-68-4
Nimotuzumab		828933-51-3
Lenvatinib mesylate		857890-39-2
Nivolumab		946414-94-4
Alirocumab		1245916-14-6
ML382		1646499-97-9
THIQ		312637-48-2
3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide		1252187-41-9
ILK-IN-3		6975-75-3
CB1 antagonist 4		1253641-65-4
Avelumab		1537032-82-8
Ripretinib		1442472-39-0
MAZ51		163655-37-6
Vedolizumab		943609-66-3
BC-DXI-843		2421117-98-6
LQZ-7I		195822-23-2
Trastuzumab		180288-69-1
trans-Benzylideneacetone		1896-62-4
Ustekinumab		815610-63-0
BENZYLACETONE		2550-26-7
Adalimumab		331731-18-1
ZSET1446		887603-94-3
Ingliforib		186392-65-4
Dehydroabietic acid		1740-19-8
ERK1/2 inhibitor 2		2095719-92-7
Raphin1 acetate		2242616-04-0
SMCC		64987-85-5
Ipilimumab		477202-00-9
Dabrafenib Mesylate		1195768-06-9
Ramucirumab		947687-13-0
Evolocumab		1256937-27-5
eCF506		1914078-41-3
3-AQC		201216-42-4
2-Phenylacetaldehyde		122-78-1
Panitumumab		339177-26-3
Obinutuzumab		949142-50-1
2,5-Dihydroxyacetophenone		490-78-8
Cetuximab		205923-56-4
Denosumab		615258-40-7
KN-92 hydrochloride		1431698-47-3
Belinostat		866323-14-0
PU02		313984-77-9
Neryl acetate		141-12-8
DihydroarteMisinic acid		85031-59-0
Atezolizumab		1380723-44-3
VLX600		327031-55-0
m-3M3FBS		200933-14-8
DNQX disodium salt		1312992-24-7
2'-Hydroxyacetophenone		118-93-4
RET V804M-IN-1		2414909-94-5
WYC-210		2131803-93-3
2-Pentylfuran		3777-69-3
Cyclic AMP		60-92-4
Alemtuzumab		216503-57-0
Ofatumumab		679818-59-8
QO-40		1259536-70-3
IQ-3		312538-03-7
SC-43		1400989-25-4

午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

TargetMol Chemicals Inc. 公司信息

公司提供產(chǎn)品列表